Le Lézard
Classified in: Health
Subjects: TDS, FDA

Qfix® Announces FDA 510(k) Clearance of Encompasstm 15 Channel Head Coil for Siemens 3T MRI Systems

AVONDALE, Pa., Sept. 12, 2019 /PRNewswire/ -- Qfix has received FDA 510(k) clearance for the Encompass 15-Channel Head Coil, a diagnostic imaging device optimized for use with the Encompasstm MR SRS Immobilization Device. 

The Encompass 15-Channel Head Coil provides diagnostic quality images for select Siemens 3T MRI Scanners. The adjustable geometry, 15-Channel coil allows the user to locate the coil elements close to the patient's anatomy. Optimal signal to noise ratio can be obtained across the entire cranium while accommodating the high precision positioning unique to the Encompass device. The Encompass MR SRS Immobilization System is part of the Qfix MRimage and Treattm line of devices, which enables patients to benefit from MR, CT, and Treatment on the same device.  MR images obtained with the Encompass MR SRS Immobilization System can be used for SRS treatment planning, including MR Only and MR Fusion techniques.

"Qfix is excited to receive clearance on our first of its kind MRI coil dedicated for use with our industry leading Encompass SRS system," said Dan Coppens, CEO of Qfix. "This technology enables the clinician to obtain superior MRI images which can be used for SRS treatment planning purposes."

Please visit Qfix at ASTRO Booth #2314 to see the latest innovations and live demonstrations of MR, CT, and treatment solutions during the American Society for Radiation Oncology (ASTRO) annual meeting, September 15-17, 2019.

About Qfix
Qfix is a world leader in radiotherapy dedicated to helping medical professionals provide the best patient care with the world's finest positioning devices designed to enhance the probability of positive patient outcomes. For more information, visit www.Qfix.com.


These press releases may also interest you

at 06:20
United Cannabis Corporation (the "Company" or "United Cannabis") announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office ("USPTO") for its application for a new patent that claims methods of...

at 06:05
Axonics Modulation Technologies, Inc. , ("Axonics"), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation ("SNM") devices for the treatment of bladder and bowel dysfunction,...

at 06:05
Health design and innovation studio GoInvo announced today that Meghana Karande, MD will join as Medical Director for the firm. Dr. Karande, a classically trained clinician via Yale and Mount Sinai, will bring her medical expertise to GoInvo's...

at 06:00
Exact Sciences Corp. today announced new outcomes data from two large population-based studies1,2 presented at the 2019 San Antonio Breast Cancer Symposium (SABCS®). The real-world evidence suggests that use of the Oncotype DX Breast Recurrence...

at 06:00
Menopause and the years preceding it have a significant impact on the health and well-being of a majority of women, but more than one-third never discuss their concerns with their health care provider (HCP), and even fewer discuss the issues that...

at 06:00
The Lung Cancer Registry has launched new surveys to do an even better job of capturing important moments in a patient's lung cancer journey. These new surveys include questions about how symptoms and side effect impact quality of life?now and over...

News published on 12 september 2019 at 16:37 and distributed by: